Insys must exit the opioid space as part of a corporate integrity agreement negotiated with the US Justice and Health and Human Services departments. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
